View ValuationHuman Creation Holdings 将来の成長Future 基準チェック /06現在、 Human Creation Holdingsの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率IT 収益成長11.3%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesReported Earnings • May 16Second quarter 2026 earnings released: JP¥11.26 loss per share (vs JP¥12.76 profit in 2Q 2025)Second quarter 2026 results: JP¥11.26 loss per share (down from JP¥12.76 profit in 2Q 2025). Revenue: JP¥2.23b (up 8.4% from 2Q 2025). Net loss: JP¥35.0m (down 185% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Reported Earnings • Feb 11First quarter 2026 earnings released: EPS: JP¥16.81 (vs JP¥40.59 in 1Q 2025)First quarter 2026 results: EPS: JP¥16.81 (down from JP¥40.59 in 1Q 2025). Revenue: JP¥2.25b (up 12% from 1Q 2025). Net income: JP¥52.0m (down 61% from 1Q 2025). Profit margin: 2.3% (down from 6.6% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.お知らせ • Dec 02Human Creation Holdings, Inc. to Report Q1, 2026 Results on Feb 10, 2026Human Creation Holdings, Inc. announced that they will report Q1, 2026 results on Feb 10, 2026分析記事 • Nov 23Some Investors May Be Willing To Look Past Human Creation Holdings' (TSE:7361) Soft EarningsThe market was pleased with the recent earnings report from Human Creation Holdings, Inc. ( TSE:7361 ), despite the...Reported Earnings • Nov 20Full year 2025 earnings released: EPS: JP¥126 (vs JP¥123 in FY 2024)Full year 2025 results: EPS: JP¥126. Revenue: JP¥8.95b (up 25% from FY 2024). Net income: JP¥398.0m (down 1.5% from FY 2024). Profit margin: 4.4% (down from 5.6% in FY 2024). The decrease in margin was driven by higher expenses.お知らせ • Nov 14Human Creation Holdings, Inc., Annual General Meeting, Dec 19, 2025Human Creation Holdings, Inc., Annual General Meeting, Dec 19, 2025.Upcoming Dividend • Sep 22Upcoming dividend of JP¥27.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 19 December 2025. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 2.3%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.2%).お知らせ • Sep 02Human Creation Holdings, Inc. to Report Fiscal Year 2025 Results on Nov 14, 2025Human Creation Holdings, Inc. announced that they will report fiscal year 2025 results on Nov 14, 2025Reported Earnings • Aug 15Third quarter 2025 earnings released: EPS: JP¥29.71 (vs JP¥33.39 in 3Q 2024)Third quarter 2025 results: EPS: JP¥29.71 (down from JP¥33.39 in 3Q 2024). Revenue: JP¥2.23b (up 21% from 3Q 2024). Net income: JP¥92.0m (down 16% from 3Q 2024). Profit margin: 4.1% (down from 6.0% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 3% per year.分析記事 • Jul 21Human Creation Holdings' (TSE:7361) Upcoming Dividend Will Be Larger Than Last Year'sThe board of Human Creation Holdings, Inc. ( TSE:7361 ) has announced that it will be paying its dividend of ¥54.00 on...Declared Dividend • Jul 21Dividend of JP¥54.00 announcedShareholders will receive a dividend of JP¥54.00. Ex-date: 29th September 2025 Payment date: 19th December 2025 Dividend yield will be 4.7%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is well covered by both earnings (21% earnings payout ratio) and cash flows (22% cash payout ratio). The dividend has increased by an average of 2.5% per year over the past 4 years and payments have been stable during that time. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Jul 20Human Creation Holdings, Inc. announces Annual dividend, payable on December 19, 2025Human Creation Holdings, Inc. announced Annual dividend of JPY 54.0000 per share payable on December 19, 2025, ex-date on September 29, 2025 and record date on September 30, 2025.お知らせ • Jun 03Human Creation Holdings, Inc. to Report Q3, 2025 Results on Aug 12, 2025Human Creation Holdings, Inc. announced that they will report Q3, 2025 results on Aug 12, 2025分析記事 • May 23Human Creation Holdings (TSE:7361) Is Posting Promising Earnings But The Good News Doesn’t Stop ThereDespite posting healthy earnings, Human Creation Holdings, Inc.'s ( TSE:7361 ) stock has been quite weak. We have done...Reported Earnings • May 14Second quarter 2025 earnings released: EPS: JP¥12.76 (vs JP¥27.62 in 2Q 2024)Second quarter 2025 results: EPS: JP¥12.76 (down from JP¥27.62 in 2Q 2024). Revenue: JP¥2.06b (up 16% from 2Q 2024). Net income: JP¥41.0m (down 55% from 2Q 2024). Profit margin: 2.0% (down from 5.1% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Apr 21Investor sentiment improves as stock rises 15%After last week's 15% share price gain to JP¥1,256, the stock trades at a trailing P/E ratio of 9x. Average trailing P/E is 16x in the IT industry in Japan. Total returns to shareholders of 20% over the past three years.分析記事 • Apr 08It's Down 25% But Human Creation Holdings, Inc. (TSE:7361) Could Be Riskier Than It LooksHuman Creation Holdings, Inc. ( TSE:7361 ) shares have had a horrible month, losing 25% after a relatively good period...New Risk • Apr 07New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.6% average weekly change). Minor Risk Market cap is less than US$100m (JP¥3.17b market cap, or US$21.7m).お知らせ • Apr 02Human Creation Holdings, Inc. (TSE:7361) completed the acquisition of Pear Capital, Inc. from Tanaka LLC, MK LLC, NJ LLC, MG LLC, NHS, LLC and others.Human Creation Holdings, Inc. (TSE:7361) agreed to acquire Pear Capital, Inc. from Tanaka LLC, MK LLC, NJ LLC, MG LLC, NHS, LLC and others for ¥1.0 billion on March 14, 2025. A cash consideration of ¥1 billion will be paid by Human Creation Holdings, Inc. As part of consideration, ¥1 billion is paid towards common equity of Pear Capital, Inc. There will be change of company name to HC Financial Advisor Co., Ltd. The expected completion of the transaction is April 10, 2025. Human Creation Holdings, Inc. (TSE:7361) completed the acquisition of Pear Capital, Inc. from Tanaka LLC, MK LLC, NJ LLC, MG LLC, NHS, LLC and others on April 1, 2025.お知らせ • Mar 04Human Creation Holdings, Inc. to Report Q2, 2025 Results on May 12, 2025Human Creation Holdings, Inc. announced that they will report Q2, 2025 results on May 12, 2025Valuation Update With 7 Day Price Move • Feb 17Investor sentiment improves as stock rises 24%After last week's 24% share price gain to JP¥1,362, the stock trades at a trailing P/E ratio of 9.9x. Average trailing P/E is 17x in the IT industry in Japan. Total returns to shareholders of 69% over the past three years.分析記事 • Feb 13Human Creation Holdings, Inc.'s (TSE:7361) Shares Leap 25% Yet They're Still Not Telling The Full StoryDespite an already strong run, Human Creation Holdings, Inc. ( TSE:7361 ) shares have been powering on, with a gain of...New Risk • Feb 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (JP¥4.25b market cap, or US$27.7m).Reported Earnings • Feb 12First quarter 2025 earnings released: EPS: JP¥81.17 (vs JP¥27.16 in 1Q 2024)First quarter 2025 results: EPS: JP¥81.17 (up from JP¥27.16 in 1Q 2024). Revenue: JP¥2.01b (up 22% from 1Q 2024). Net income: JP¥132.0m (up 48% from 1Q 2024). Profit margin: 6.6% (up from 5.4% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.お知らせ • Dec 13Human Creation Holdings, Inc. (TSE:7361) announces an Equity Buyback for 239,000 shares, representing 7.35% for ¥220 million.Human Creation Holdings, Inc. (TSE:7361) announces a share repurchase program. Under the program, the company will repurchase up to 239,000 shares, representing 7.35% of its issued share capital post stock-split for ¥220 million. The purpose of repurchase program is to enhance shareholder returns and improve capital efficiency. The program will run until June 30, 2025. As of November 30, 2024, the company had 1,626,205 shares in issue (excluding treasury stock) representing 32,52,410 share after stock-split effective from December 30, 2024 and 160,345 shares (6,504,820 shares post stock-split).お知らせ • Dec 03Human Creation Holdings, Inc. to Report Q1, 2025 Results on Feb 10, 2025Human Creation Holdings, Inc. announced that they will report Q1, 2025 results on Feb 10, 2025分析記事 • Nov 22There May Be Reason For Hope In Human Creation Holdings' (TSE:7361) Disappointing EarningsSoft earnings didn't appear to concern Human Creation Holdings, Inc.'s ( TSE:7361 ) shareholders over the last week...Reported Earnings • Nov 17Full year 2024 earnings released: EPS: JP¥246 (vs JP¥264 in FY 2023)Full year 2024 results: EPS: JP¥246 (down from JP¥264 in FY 2023). Revenue: JP¥7.17b (up 11% from FY 2023). Net income: JP¥404.0m (down 7.8% from FY 2023). Profit margin: 5.6% (down from 6.8% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.お知らせ • Nov 15Human Creation Holdings, Inc., Annual General Meeting, Dec 18, 2024Human Creation Holdings, Inc., Annual General Meeting, Dec 18, 2024.Upcoming Dividend • Sep 20Upcoming dividend of JP¥52.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 18 December 2024. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (1.4%).お知らせ • Sep 02Human Creation Holdings, Inc. to Report Fiscal Year 2024 Results on Nov 14, 2024Human Creation Holdings, Inc. announced that they will report fiscal year 2024 results on Nov 14, 2024Reported Earnings • Aug 14Third quarter 2024 earnings released: EPS: JP¥66.78 (vs JP¥76.91 in 3Q 2023)Third quarter 2024 results: EPS: JP¥66.78 (down from JP¥76.91 in 3Q 2023). Revenue: JP¥1.85b (up 10% from 3Q 2023). Net income: JP¥110.0m (down 13% from 3Q 2023). Profit margin: 6.0% (down from 7.5% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.分析記事 • Aug 07Human Creation Holdings (TSE:7361) Could Easily Take On More DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to JP¥1,701, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 17x in the IT industry in Japan. Total loss to shareholders of 39% over the past three years.お知らせ • Jun 06Human Creation Holdings, Inc. to Report Q3, 2024 Results on Aug 09, 2024Human Creation Holdings, Inc. announced that they will report Q3, 2024 results on Aug 09, 2024分析記事 • May 21Human Creation Holdings' (TSE:7361) Soft Earnings Are Actually Better Than They AppearSoft earnings didn't appear to concern Human Creation Holdings, Inc.'s ( TSE:7361 ) shareholders over the last week. We...Reported Earnings • May 13Second quarter 2024 earnings released: EPS: JP¥55.24 (vs JP¥73.34 in 2Q 2023)Second quarter 2024 results: EPS: JP¥55.24 (down from JP¥73.34 in 2Q 2023). Revenue: JP¥1.77b (up 9.3% from 2Q 2023). Net income: JP¥91.0m (down 24% from 2Q 2023). Profit margin: 5.1% (down from 7.4% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.4% p.a. on average during the next 2 years, compared to a 4.9% growth forecast for the IT industry in Japan.お知らせ • May 11Human Creation Holdings, Inc. (TSE:7361) announces an Equity Buyback for 24,000 shares, representing 1.45% for ¥48 million.Human Creation Holdings, Inc. (TSE:7361) announces a share repurchase program. Under the program, the company will repurchase up to 24,000 shares, representing 1.45% for ¥48 million. The purpose of repurchase program is to enhance shareholder returns and improve capital efficiency. The program will run until August 31, 2024. As of March 31, 2024, the company had 1,649,505 shares in issue (excluding treasury stock).お知らせ • Mar 03Human Creation Holdings, Inc. to Report Q2, 2024 Results on May 10, 2024Human Creation Holdings, Inc. announced that they will report Q2, 2024 results on May 10, 2024Board Change • Feb 21Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 7 experienced directors. 1 highly experienced director. 2 independent directors (5 non-independent directors). Independent Outside Director Tatsuki Niimi was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Feb 11First quarter 2024 earnings released: EPS: JP¥54.32 (vs JP¥57.83 in 1Q 2023)First quarter 2024 results: EPS: JP¥54.32 (down from JP¥57.83 in 1Q 2023). Revenue: JP¥1.65b (up 5.4% from 1Q 2023). Net income: JP¥89.0m (down 10% from 1Q 2023). Profit margin: 5.4% (down from 6.3% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.8% p.a. on average during the next 2 years, compared to a 5.5% growth forecast for the IT industry in Japan.お知らせ • Dec 03Human Creation Holdings, Inc. to Report Q1, 2024 Results on Feb 09, 2024Human Creation Holdings, Inc. announced that they will report Q1, 2024 results on Feb 09, 2024Reported Earnings • Nov 20Full year 2023 earnings: EPS and revenues exceed analyst expectationsFull year 2023 results: EPS: JP¥264 (up from JP¥189 in FY 2022). Revenue: JP¥6.49b (up 12% from FY 2022). Net income: JP¥438.0m (up 28% from FY 2022). Profit margin: 6.8% (up from 5.9% in FY 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) also surpassed analyst estimates by 19%. Revenue is forecast to grow 5.7% p.a. on average during the next 2 years, compared to a 5.6% growth forecast for the IT industry in Japan.お知らせ • Nov 17Human Creation Holdings, Inc., Annual General Meeting, Dec 15, 2023Human Creation Holdings, Inc., Annual General Meeting, Dec 15, 2023.Upcoming Dividend • Sep 21Upcoming dividend of JP¥51.00 per share at 1.9% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 18 December 2023. Payout ratio is a comfortable 18% but the company is paying out more than the cash it is generating. Trailing yield: 1.9%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.5%).お知らせ • Sep 02Human Creation Holdings, Inc. to Report Fiscal Year 2023 Results on Nov 14, 2023Human Creation Holdings, Inc. announced that they will report fiscal year 2023 results on Nov 14, 2023New Risk • Aug 09New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 1.3% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 1.3% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (334% cash payout ratio). Market cap is less than US$100m (JP¥4.58b market cap, or US$32.0m).Reported Earnings • Aug 08Third quarter 2023 earnings released: EPS: JP¥76.91 (vs JP¥47.60 in 3Q 2022)Third quarter 2023 results: EPS: JP¥76.91 (up from JP¥47.60 in 3Q 2022). Revenue: JP¥1.67b (up 11% from 3Q 2022). Net income: JP¥126.0m (up 48% from 3Q 2022). Profit margin: 7.5% (up from 5.6% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the IT industry in Japan.お知らせ • Jun 03Human Creation Holdings, Inc. to Report Q3, 2023 Results on Aug 07, 2023Human Creation Holdings, Inc. announced that they will report Q3, 2023 results on Aug 07, 2023Reported Earnings • May 12Second quarter 2023 earnings released: EPS: JP¥73.34 (vs JP¥47.83 in 2Q 2022)Second quarter 2023 results: EPS: JP¥73.34 (up from JP¥47.83 in 2Q 2022). Revenue: JP¥1.62b (up 17% from 2Q 2022). Net income: JP¥120.0m (up 38% from 2Q 2022). Profit margin: 7.4% (up from 6.3% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the IT industry in Japan.Valuation Update With 7 Day Price Move • May 11Investor sentiment improves as stock rises 16%After last week's 16% share price gain to JP¥2,570, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 18x in the IT industry in Japan. Total returns to shareholders of 27% over the past year.Reported Earnings • Feb 12First quarter 2023 earnings released: EPS: JP¥57.83 (vs JP¥20.43 in 1Q 2022)First quarter 2023 results: EPS: JP¥57.83 (up from JP¥20.43 in 1Q 2022). Revenue: JP¥1.56b (up 15% from 1Q 2022). Net income: JP¥99.0m (up 154% from 1Q 2022). Profit margin: 6.3% (up from 2.9% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the IT industry in Japan.お知らせ • Dec 16Human Creation Holdings, Inc. (TSE:7361) announces an Equity Buyback.Human Creation Holdings, Inc. (TSE:7361) announces a share repurchase program. Under the program, the company will repurchase its own shares from Risa Partners, Inc. The shares will be repurchased at a price ¥2,156 per share. The program will run until March 31, 2023. As of September 30, 2022, the company had 1,926,550 shares in issue.お知らせ • Dec 04Human Creation Holdings, Inc. to Report Q1, 2023 Results on Feb 10, 2023Human Creation Holdings, Inc. announced that they will report Q1, 2023 results on Feb 10, 2023Reported Earnings • Nov 17Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: JP¥189 (up from JP¥146 in FY 2021). Revenue: JP¥5.80b (up 15% from FY 2021). Net income: JP¥343.0m (up 25% from FY 2021). Profit margin: 5.9% (up from 5.5% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.5%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 6.6% growth forecast for the IT industry in Japan.お知らせ • Nov 16Human Creation Holdings, Inc., Annual General Meeting, Dec 15, 2022Human Creation Holdings, Inc., Annual General Meeting, Dec 15, 2022.Upcoming Dividend • Sep 22Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 16 December 2022. Trailing yield: 2.5%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.7%).お知らせ • Sep 03Human Creation Holdings, Inc. to Report Fiscal Year 2022 Results on Nov 14, 2022Human Creation Holdings, Inc. announced that they will report fiscal year 2022 results on Nov 14, 2022Reported Earnings • Aug 09Third quarter 2022 earnings released: EPS: JP¥47.60 (vs JP¥32.70 in 3Q 2021)Third quarter 2022 results: EPS: JP¥47.60 (up from JP¥32.70 in 3Q 2021). Revenue: JP¥1.51b (up 15% from 3Q 2021). Net income: JP¥85.0m (up 35% from 3Q 2021). Profit margin: 5.6% (up from 4.8% in 3Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 15%, compared to a 11% growth forecast for the industry in Japan.お知らせ • Jun 03Human Creation Holdings, Inc. to Report Q3, 2022 Results on Aug 08, 2022Human Creation Holdings, Inc. announced that they will report Q3, 2022 results on Aug 08, 2022Reported Earnings • May 11Second quarter 2022 earnings releasedSecond quarter 2022 results: EPS: JP¥47.83. Revenue: JP¥1.39b (flat on 2Q 2021). Net income: JP¥87.0m (up JP¥87.0m from 2Q 2021). Profit margin: 6.3% (up from null in 2Q 2021). Over the next year, revenue is forecast to grow 12%, compared to a 7.9% growth forecast for the industry in Japan.お知らせ • Apr 08Human Creation Holdings, Inc. to Report Q2, 2022 Results on May 10, 2022Human Creation Holdings, Inc. announced that they will report Q2, 2022 results on May 10, 2022Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to JP¥2,280, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 19x in the IT industry in Japan. Total loss to shareholders of 4.9% over the past year.Reported Earnings • Feb 15First quarter 2022 earnings: Revenues and EPS in line with analyst expectationsFirst quarter 2022 results: EPS: JP¥20.43. Revenue: JP¥1.36b (flat on 1Q 2021). Net income: JP¥39.0m (up JP¥39.0m from 1Q 2021). Profit margin: 2.9% (up from null in 1Q 2021). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 12%, compared to a 7.2% growth forecast for the industry in Japan.お知らせ • Feb 11Human Creation Holdings, Inc. (TSE:7361) announces an Equity Buyback for 100,000 shares, representing 5.19% for ¥200 million.Human Creation Holdings, Inc. (TSE:7361) announces a share repurchase program. Under the program, the company will repurchase up to 100,000 shares, representing 5.19% of its issued share capital (excluding treasury stock), for a total purchase price of ¥200 million. The purpose of the program is to enhance shareholder returns and improve capital efficiency. The program will continue through September 30, 2022. As of September 30, 2021, the company had 1,926,392 issued shares (excluding treasury stock) and 185 treasury shares.Reported Earnings • Nov 17Full year 2021 earnings released: EPS JP¥146 (vs JP¥116 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥5.04b (up 10% from FY 2020). Net income: JP¥275.0m (up 31% from FY 2020). Profit margin: 5.5% (up from 4.6% in FY 2020). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Aug 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to JP¥2,827, the stock trades at a trailing P/E ratio of 24.3x. Average trailing P/E is 21x in the IT industry in Japan.Valuation Update With 7 Day Price Move • Aug 02Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to JP¥3,320, the stock trades at a trailing P/E ratio of 28.6x. Average trailing P/E is 23x in the IT industry in Japan.Valuation Update With 7 Day Price Move • Jun 17Investor sentiment improved over the past weekAfter last week's 15% share price gain to JP¥3,415, the stock trades at a trailing P/E ratio of 29.4x. Average trailing P/E is 25x in the IT industry in Japan.Valuation Update With 7 Day Price Move • May 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to JP¥2,860, the stock trades at a trailing P/E ratio of 24.6x. Average trailing P/E is 25x in the IT industry in Japan.お知らせ • Mar 18Human Creation Holdings, Inc. has completed an IPO in the amount of ¥3.433128 billion.Human Creation Holdings, Inc. has completed an IPO in the amount of ¥3.433128 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,619,400 Price\Range: ¥2120 Discount Per Security: ¥169.6 Transaction Features: ESOP Related Offering このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Human Creation Holdings は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測TSE:7361 - アナリストの将来予測と過去の財務データ ( )JPY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20269,351242633644N/A12/31/20259,178318N/AN/AN/A9/30/20258,9453989661,029N/A6/30/20258,200379N/AN/AN/A3/31/20257,818397378453N/A12/31/20247,530447N/AN/AN/A9/30/20247,165404475481N/A6/30/20246,895383N/AN/AN/A3/31/20246,7213991,1311,145N/A12/31/20236,571428N/AN/AN/A9/30/20236,486438705722N/A6/30/20236,400477N/AN/AN/A3/31/20236,2344362534N/A12/31/20226,002403N/AN/AN/A9/30/20225,803343370373N/A6/30/20225,567274N/AN/AN/A3/31/20225,284228452451N/A12/31/20215,189235N/AN/AN/A9/30/20215,035275257267N/A9/30/20204,565210N/AN/AN/A9/30/20194,154203N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 7361の予測収益成長が 貯蓄率 ( 0.8% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 7361の収益がJP市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 7361の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 7361の収益がJP市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 7361の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 7361の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YSoftware 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 11:08終値2026/05/22 00:00収益2026/03/31年間収益2025/09/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Human Creation Holdings, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Atsushi OhmachiThe Stock Research Center
Reported Earnings • May 16Second quarter 2026 earnings released: JP¥11.26 loss per share (vs JP¥12.76 profit in 2Q 2025)Second quarter 2026 results: JP¥11.26 loss per share (down from JP¥12.76 profit in 2Q 2025). Revenue: JP¥2.23b (up 8.4% from 2Q 2025). Net loss: JP¥35.0m (down 185% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Reported Earnings • Feb 11First quarter 2026 earnings released: EPS: JP¥16.81 (vs JP¥40.59 in 1Q 2025)First quarter 2026 results: EPS: JP¥16.81 (down from JP¥40.59 in 1Q 2025). Revenue: JP¥2.25b (up 12% from 1Q 2025). Net income: JP¥52.0m (down 61% from 1Q 2025). Profit margin: 2.3% (down from 6.6% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
お知らせ • Dec 02Human Creation Holdings, Inc. to Report Q1, 2026 Results on Feb 10, 2026Human Creation Holdings, Inc. announced that they will report Q1, 2026 results on Feb 10, 2026
分析記事 • Nov 23Some Investors May Be Willing To Look Past Human Creation Holdings' (TSE:7361) Soft EarningsThe market was pleased with the recent earnings report from Human Creation Holdings, Inc. ( TSE:7361 ), despite the...
Reported Earnings • Nov 20Full year 2025 earnings released: EPS: JP¥126 (vs JP¥123 in FY 2024)Full year 2025 results: EPS: JP¥126. Revenue: JP¥8.95b (up 25% from FY 2024). Net income: JP¥398.0m (down 1.5% from FY 2024). Profit margin: 4.4% (down from 5.6% in FY 2024). The decrease in margin was driven by higher expenses.
お知らせ • Nov 14Human Creation Holdings, Inc., Annual General Meeting, Dec 19, 2025Human Creation Holdings, Inc., Annual General Meeting, Dec 19, 2025.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥27.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 19 December 2025. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 2.3%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.2%).
お知らせ • Sep 02Human Creation Holdings, Inc. to Report Fiscal Year 2025 Results on Nov 14, 2025Human Creation Holdings, Inc. announced that they will report fiscal year 2025 results on Nov 14, 2025
Reported Earnings • Aug 15Third quarter 2025 earnings released: EPS: JP¥29.71 (vs JP¥33.39 in 3Q 2024)Third quarter 2025 results: EPS: JP¥29.71 (down from JP¥33.39 in 3Q 2024). Revenue: JP¥2.23b (up 21% from 3Q 2024). Net income: JP¥92.0m (down 16% from 3Q 2024). Profit margin: 4.1% (down from 6.0% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 3% per year.
分析記事 • Jul 21Human Creation Holdings' (TSE:7361) Upcoming Dividend Will Be Larger Than Last Year'sThe board of Human Creation Holdings, Inc. ( TSE:7361 ) has announced that it will be paying its dividend of ¥54.00 on...
Declared Dividend • Jul 21Dividend of JP¥54.00 announcedShareholders will receive a dividend of JP¥54.00. Ex-date: 29th September 2025 Payment date: 19th December 2025 Dividend yield will be 4.7%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is well covered by both earnings (21% earnings payout ratio) and cash flows (22% cash payout ratio). The dividend has increased by an average of 2.5% per year over the past 4 years and payments have been stable during that time. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Jul 20Human Creation Holdings, Inc. announces Annual dividend, payable on December 19, 2025Human Creation Holdings, Inc. announced Annual dividend of JPY 54.0000 per share payable on December 19, 2025, ex-date on September 29, 2025 and record date on September 30, 2025.
お知らせ • Jun 03Human Creation Holdings, Inc. to Report Q3, 2025 Results on Aug 12, 2025Human Creation Holdings, Inc. announced that they will report Q3, 2025 results on Aug 12, 2025
分析記事 • May 23Human Creation Holdings (TSE:7361) Is Posting Promising Earnings But The Good News Doesn’t Stop ThereDespite posting healthy earnings, Human Creation Holdings, Inc.'s ( TSE:7361 ) stock has been quite weak. We have done...
Reported Earnings • May 14Second quarter 2025 earnings released: EPS: JP¥12.76 (vs JP¥27.62 in 2Q 2024)Second quarter 2025 results: EPS: JP¥12.76 (down from JP¥27.62 in 2Q 2024). Revenue: JP¥2.06b (up 16% from 2Q 2024). Net income: JP¥41.0m (down 55% from 2Q 2024). Profit margin: 2.0% (down from 5.1% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Apr 21Investor sentiment improves as stock rises 15%After last week's 15% share price gain to JP¥1,256, the stock trades at a trailing P/E ratio of 9x. Average trailing P/E is 16x in the IT industry in Japan. Total returns to shareholders of 20% over the past three years.
分析記事 • Apr 08It's Down 25% But Human Creation Holdings, Inc. (TSE:7361) Could Be Riskier Than It LooksHuman Creation Holdings, Inc. ( TSE:7361 ) shares have had a horrible month, losing 25% after a relatively good period...
New Risk • Apr 07New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.6% average weekly change). Minor Risk Market cap is less than US$100m (JP¥3.17b market cap, or US$21.7m).
お知らせ • Apr 02Human Creation Holdings, Inc. (TSE:7361) completed the acquisition of Pear Capital, Inc. from Tanaka LLC, MK LLC, NJ LLC, MG LLC, NHS, LLC and others.Human Creation Holdings, Inc. (TSE:7361) agreed to acquire Pear Capital, Inc. from Tanaka LLC, MK LLC, NJ LLC, MG LLC, NHS, LLC and others for ¥1.0 billion on March 14, 2025. A cash consideration of ¥1 billion will be paid by Human Creation Holdings, Inc. As part of consideration, ¥1 billion is paid towards common equity of Pear Capital, Inc. There will be change of company name to HC Financial Advisor Co., Ltd. The expected completion of the transaction is April 10, 2025. Human Creation Holdings, Inc. (TSE:7361) completed the acquisition of Pear Capital, Inc. from Tanaka LLC, MK LLC, NJ LLC, MG LLC, NHS, LLC and others on April 1, 2025.
お知らせ • Mar 04Human Creation Holdings, Inc. to Report Q2, 2025 Results on May 12, 2025Human Creation Holdings, Inc. announced that they will report Q2, 2025 results on May 12, 2025
Valuation Update With 7 Day Price Move • Feb 17Investor sentiment improves as stock rises 24%After last week's 24% share price gain to JP¥1,362, the stock trades at a trailing P/E ratio of 9.9x. Average trailing P/E is 17x in the IT industry in Japan. Total returns to shareholders of 69% over the past three years.
分析記事 • Feb 13Human Creation Holdings, Inc.'s (TSE:7361) Shares Leap 25% Yet They're Still Not Telling The Full StoryDespite an already strong run, Human Creation Holdings, Inc. ( TSE:7361 ) shares have been powering on, with a gain of...
New Risk • Feb 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (JP¥4.25b market cap, or US$27.7m).
Reported Earnings • Feb 12First quarter 2025 earnings released: EPS: JP¥81.17 (vs JP¥27.16 in 1Q 2024)First quarter 2025 results: EPS: JP¥81.17 (up from JP¥27.16 in 1Q 2024). Revenue: JP¥2.01b (up 22% from 1Q 2024). Net income: JP¥132.0m (up 48% from 1Q 2024). Profit margin: 6.6% (up from 5.4% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
お知らせ • Dec 13Human Creation Holdings, Inc. (TSE:7361) announces an Equity Buyback for 239,000 shares, representing 7.35% for ¥220 million.Human Creation Holdings, Inc. (TSE:7361) announces a share repurchase program. Under the program, the company will repurchase up to 239,000 shares, representing 7.35% of its issued share capital post stock-split for ¥220 million. The purpose of repurchase program is to enhance shareholder returns and improve capital efficiency. The program will run until June 30, 2025. As of November 30, 2024, the company had 1,626,205 shares in issue (excluding treasury stock) representing 32,52,410 share after stock-split effective from December 30, 2024 and 160,345 shares (6,504,820 shares post stock-split).
お知らせ • Dec 03Human Creation Holdings, Inc. to Report Q1, 2025 Results on Feb 10, 2025Human Creation Holdings, Inc. announced that they will report Q1, 2025 results on Feb 10, 2025
分析記事 • Nov 22There May Be Reason For Hope In Human Creation Holdings' (TSE:7361) Disappointing EarningsSoft earnings didn't appear to concern Human Creation Holdings, Inc.'s ( TSE:7361 ) shareholders over the last week...
Reported Earnings • Nov 17Full year 2024 earnings released: EPS: JP¥246 (vs JP¥264 in FY 2023)Full year 2024 results: EPS: JP¥246 (down from JP¥264 in FY 2023). Revenue: JP¥7.17b (up 11% from FY 2023). Net income: JP¥404.0m (down 7.8% from FY 2023). Profit margin: 5.6% (down from 6.8% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
お知らせ • Nov 15Human Creation Holdings, Inc., Annual General Meeting, Dec 18, 2024Human Creation Holdings, Inc., Annual General Meeting, Dec 18, 2024.
Upcoming Dividend • Sep 20Upcoming dividend of JP¥52.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 18 December 2024. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (1.4%).
お知らせ • Sep 02Human Creation Holdings, Inc. to Report Fiscal Year 2024 Results on Nov 14, 2024Human Creation Holdings, Inc. announced that they will report fiscal year 2024 results on Nov 14, 2024
Reported Earnings • Aug 14Third quarter 2024 earnings released: EPS: JP¥66.78 (vs JP¥76.91 in 3Q 2023)Third quarter 2024 results: EPS: JP¥66.78 (down from JP¥76.91 in 3Q 2023). Revenue: JP¥1.85b (up 10% from 3Q 2023). Net income: JP¥110.0m (down 13% from 3Q 2023). Profit margin: 6.0% (down from 7.5% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
分析記事 • Aug 07Human Creation Holdings (TSE:7361) Could Easily Take On More DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to JP¥1,701, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 17x in the IT industry in Japan. Total loss to shareholders of 39% over the past three years.
お知らせ • Jun 06Human Creation Holdings, Inc. to Report Q3, 2024 Results on Aug 09, 2024Human Creation Holdings, Inc. announced that they will report Q3, 2024 results on Aug 09, 2024
分析記事 • May 21Human Creation Holdings' (TSE:7361) Soft Earnings Are Actually Better Than They AppearSoft earnings didn't appear to concern Human Creation Holdings, Inc.'s ( TSE:7361 ) shareholders over the last week. We...
Reported Earnings • May 13Second quarter 2024 earnings released: EPS: JP¥55.24 (vs JP¥73.34 in 2Q 2023)Second quarter 2024 results: EPS: JP¥55.24 (down from JP¥73.34 in 2Q 2023). Revenue: JP¥1.77b (up 9.3% from 2Q 2023). Net income: JP¥91.0m (down 24% from 2Q 2023). Profit margin: 5.1% (down from 7.4% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.4% p.a. on average during the next 2 years, compared to a 4.9% growth forecast for the IT industry in Japan.
お知らせ • May 11Human Creation Holdings, Inc. (TSE:7361) announces an Equity Buyback for 24,000 shares, representing 1.45% for ¥48 million.Human Creation Holdings, Inc. (TSE:7361) announces a share repurchase program. Under the program, the company will repurchase up to 24,000 shares, representing 1.45% for ¥48 million. The purpose of repurchase program is to enhance shareholder returns and improve capital efficiency. The program will run until August 31, 2024. As of March 31, 2024, the company had 1,649,505 shares in issue (excluding treasury stock).
お知らせ • Mar 03Human Creation Holdings, Inc. to Report Q2, 2024 Results on May 10, 2024Human Creation Holdings, Inc. announced that they will report Q2, 2024 results on May 10, 2024
Board Change • Feb 21Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 7 experienced directors. 1 highly experienced director. 2 independent directors (5 non-independent directors). Independent Outside Director Tatsuki Niimi was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Feb 11First quarter 2024 earnings released: EPS: JP¥54.32 (vs JP¥57.83 in 1Q 2023)First quarter 2024 results: EPS: JP¥54.32 (down from JP¥57.83 in 1Q 2023). Revenue: JP¥1.65b (up 5.4% from 1Q 2023). Net income: JP¥89.0m (down 10% from 1Q 2023). Profit margin: 5.4% (down from 6.3% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.8% p.a. on average during the next 2 years, compared to a 5.5% growth forecast for the IT industry in Japan.
お知らせ • Dec 03Human Creation Holdings, Inc. to Report Q1, 2024 Results on Feb 09, 2024Human Creation Holdings, Inc. announced that they will report Q1, 2024 results on Feb 09, 2024
Reported Earnings • Nov 20Full year 2023 earnings: EPS and revenues exceed analyst expectationsFull year 2023 results: EPS: JP¥264 (up from JP¥189 in FY 2022). Revenue: JP¥6.49b (up 12% from FY 2022). Net income: JP¥438.0m (up 28% from FY 2022). Profit margin: 6.8% (up from 5.9% in FY 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) also surpassed analyst estimates by 19%. Revenue is forecast to grow 5.7% p.a. on average during the next 2 years, compared to a 5.6% growth forecast for the IT industry in Japan.
お知らせ • Nov 17Human Creation Holdings, Inc., Annual General Meeting, Dec 15, 2023Human Creation Holdings, Inc., Annual General Meeting, Dec 15, 2023.
Upcoming Dividend • Sep 21Upcoming dividend of JP¥51.00 per share at 1.9% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 18 December 2023. Payout ratio is a comfortable 18% but the company is paying out more than the cash it is generating. Trailing yield: 1.9%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.5%).
お知らせ • Sep 02Human Creation Holdings, Inc. to Report Fiscal Year 2023 Results on Nov 14, 2023Human Creation Holdings, Inc. announced that they will report fiscal year 2023 results on Nov 14, 2023
New Risk • Aug 09New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 1.3% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 1.3% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (334% cash payout ratio). Market cap is less than US$100m (JP¥4.58b market cap, or US$32.0m).
Reported Earnings • Aug 08Third quarter 2023 earnings released: EPS: JP¥76.91 (vs JP¥47.60 in 3Q 2022)Third quarter 2023 results: EPS: JP¥76.91 (up from JP¥47.60 in 3Q 2022). Revenue: JP¥1.67b (up 11% from 3Q 2022). Net income: JP¥126.0m (up 48% from 3Q 2022). Profit margin: 7.5% (up from 5.6% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the IT industry in Japan.
お知らせ • Jun 03Human Creation Holdings, Inc. to Report Q3, 2023 Results on Aug 07, 2023Human Creation Holdings, Inc. announced that they will report Q3, 2023 results on Aug 07, 2023
Reported Earnings • May 12Second quarter 2023 earnings released: EPS: JP¥73.34 (vs JP¥47.83 in 2Q 2022)Second quarter 2023 results: EPS: JP¥73.34 (up from JP¥47.83 in 2Q 2022). Revenue: JP¥1.62b (up 17% from 2Q 2022). Net income: JP¥120.0m (up 38% from 2Q 2022). Profit margin: 7.4% (up from 6.3% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the IT industry in Japan.
Valuation Update With 7 Day Price Move • May 11Investor sentiment improves as stock rises 16%After last week's 16% share price gain to JP¥2,570, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 18x in the IT industry in Japan. Total returns to shareholders of 27% over the past year.
Reported Earnings • Feb 12First quarter 2023 earnings released: EPS: JP¥57.83 (vs JP¥20.43 in 1Q 2022)First quarter 2023 results: EPS: JP¥57.83 (up from JP¥20.43 in 1Q 2022). Revenue: JP¥1.56b (up 15% from 1Q 2022). Net income: JP¥99.0m (up 154% from 1Q 2022). Profit margin: 6.3% (up from 2.9% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the IT industry in Japan.
お知らせ • Dec 16Human Creation Holdings, Inc. (TSE:7361) announces an Equity Buyback.Human Creation Holdings, Inc. (TSE:7361) announces a share repurchase program. Under the program, the company will repurchase its own shares from Risa Partners, Inc. The shares will be repurchased at a price ¥2,156 per share. The program will run until March 31, 2023. As of September 30, 2022, the company had 1,926,550 shares in issue.
お知らせ • Dec 04Human Creation Holdings, Inc. to Report Q1, 2023 Results on Feb 10, 2023Human Creation Holdings, Inc. announced that they will report Q1, 2023 results on Feb 10, 2023
Reported Earnings • Nov 17Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: JP¥189 (up from JP¥146 in FY 2021). Revenue: JP¥5.80b (up 15% from FY 2021). Net income: JP¥343.0m (up 25% from FY 2021). Profit margin: 5.9% (up from 5.5% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.5%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 6.6% growth forecast for the IT industry in Japan.
お知らせ • Nov 16Human Creation Holdings, Inc., Annual General Meeting, Dec 15, 2022Human Creation Holdings, Inc., Annual General Meeting, Dec 15, 2022.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 16 December 2022. Trailing yield: 2.5%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.7%).
お知らせ • Sep 03Human Creation Holdings, Inc. to Report Fiscal Year 2022 Results on Nov 14, 2022Human Creation Holdings, Inc. announced that they will report fiscal year 2022 results on Nov 14, 2022
Reported Earnings • Aug 09Third quarter 2022 earnings released: EPS: JP¥47.60 (vs JP¥32.70 in 3Q 2021)Third quarter 2022 results: EPS: JP¥47.60 (up from JP¥32.70 in 3Q 2021). Revenue: JP¥1.51b (up 15% from 3Q 2021). Net income: JP¥85.0m (up 35% from 3Q 2021). Profit margin: 5.6% (up from 4.8% in 3Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 15%, compared to a 11% growth forecast for the industry in Japan.
お知らせ • Jun 03Human Creation Holdings, Inc. to Report Q3, 2022 Results on Aug 08, 2022Human Creation Holdings, Inc. announced that they will report Q3, 2022 results on Aug 08, 2022
Reported Earnings • May 11Second quarter 2022 earnings releasedSecond quarter 2022 results: EPS: JP¥47.83. Revenue: JP¥1.39b (flat on 2Q 2021). Net income: JP¥87.0m (up JP¥87.0m from 2Q 2021). Profit margin: 6.3% (up from null in 2Q 2021). Over the next year, revenue is forecast to grow 12%, compared to a 7.9% growth forecast for the industry in Japan.
お知らせ • Apr 08Human Creation Holdings, Inc. to Report Q2, 2022 Results on May 10, 2022Human Creation Holdings, Inc. announced that they will report Q2, 2022 results on May 10, 2022
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to JP¥2,280, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 19x in the IT industry in Japan. Total loss to shareholders of 4.9% over the past year.
Reported Earnings • Feb 15First quarter 2022 earnings: Revenues and EPS in line with analyst expectationsFirst quarter 2022 results: EPS: JP¥20.43. Revenue: JP¥1.36b (flat on 1Q 2021). Net income: JP¥39.0m (up JP¥39.0m from 1Q 2021). Profit margin: 2.9% (up from null in 1Q 2021). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 12%, compared to a 7.2% growth forecast for the industry in Japan.
お知らせ • Feb 11Human Creation Holdings, Inc. (TSE:7361) announces an Equity Buyback for 100,000 shares, representing 5.19% for ¥200 million.Human Creation Holdings, Inc. (TSE:7361) announces a share repurchase program. Under the program, the company will repurchase up to 100,000 shares, representing 5.19% of its issued share capital (excluding treasury stock), for a total purchase price of ¥200 million. The purpose of the program is to enhance shareholder returns and improve capital efficiency. The program will continue through September 30, 2022. As of September 30, 2021, the company had 1,926,392 issued shares (excluding treasury stock) and 185 treasury shares.
Reported Earnings • Nov 17Full year 2021 earnings released: EPS JP¥146 (vs JP¥116 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥5.04b (up 10% from FY 2020). Net income: JP¥275.0m (up 31% from FY 2020). Profit margin: 5.5% (up from 4.6% in FY 2020). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Aug 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to JP¥2,827, the stock trades at a trailing P/E ratio of 24.3x. Average trailing P/E is 21x in the IT industry in Japan.
Valuation Update With 7 Day Price Move • Aug 02Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to JP¥3,320, the stock trades at a trailing P/E ratio of 28.6x. Average trailing P/E is 23x in the IT industry in Japan.
Valuation Update With 7 Day Price Move • Jun 17Investor sentiment improved over the past weekAfter last week's 15% share price gain to JP¥3,415, the stock trades at a trailing P/E ratio of 29.4x. Average trailing P/E is 25x in the IT industry in Japan.
Valuation Update With 7 Day Price Move • May 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to JP¥2,860, the stock trades at a trailing P/E ratio of 24.6x. Average trailing P/E is 25x in the IT industry in Japan.
お知らせ • Mar 18Human Creation Holdings, Inc. has completed an IPO in the amount of ¥3.433128 billion.Human Creation Holdings, Inc. has completed an IPO in the amount of ¥3.433128 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,619,400 Price\Range: ¥2120 Discount Per Security: ¥169.6 Transaction Features: ESOP Related Offering